You are here
- Home
- Diseases & Conditions
- All Diseases and Conditions
A Study to Assess the Absolute Bioavailability of a Single Oral Dose of Fostamatinib with Respect to an Intravenous Micro Tracer Dose of [14C] R406 in Healthy Male Volunteers
- Disease
- bioavailability
- Drug Name
- Fostamatinib Disodium
- Generic Name
- Fostamatinib
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- May 29, 2012
- Study Name
- QBR112696
- Study Id
- D4300C00027
- ClinicalTrials.gov ID
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
